4.85
price down icon3.00%   -0.15
after-market Handel nachbörslich: 4.99 0.14 +2.89%
loading

Corvus Pharmaceuticals Inc Aktie (CRVS) Neueste Nachrichten

pulisher
09:04 AM

A Tale of Resilience: Corvus Pharmaceuticals Inc Amid Stock Market Turbulence - investchronicle.com

09:04 AM
pulisher
04:04 AM

How Resilient Is Corvus Pharmaceuticals Inc. Stock During Economic DownturnsEarnings Risk Report & High Yield Stock Recommendations - Newser

04:04 AM
pulisher
03:35 AM

Is Corvus Pharmaceuticals Inc. stock entering bullish territoryJuly 2025 Macro Moves & Daily Growth Stock Tips - Newser

03:35 AM
pulisher
01:32 AM

Pattern recognition hints at Corvus Pharmaceuticals Inc. upsideQuarterly Market Summary & Reliable Breakout Forecasts - Newser

01:32 AM
pulisher
01:30 AM

Sentiment analysis tools applied to Corvus Pharmaceuticals Inc.2025 Valuation Update & Long Hold Capital Preservation Tips - Newser

01:30 AM
pulisher
01:06 AM

Can swing trading help recover from Corvus Pharmaceuticals Inc. losses2025 Volume Leaders & Daily Risk Controlled Trade Plans - Newser

01:06 AM
pulisher
Aug 13, 2025

What to expect from Corvus Pharmaceuticals Inc. in the next 30 daysPortfolio Gains Report & Accurate Buy Signal Notifications - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Corvus Pharmaceuticals’ Earnings Call Highlights Progress - MSN

Aug 13, 2025
pulisher
Aug 13, 2025

Can volume confirm reversal in Corvus Pharmaceuticals Inc.Long Setup & Risk Controlled Daily Trade Plans - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Corvus Pharmaceuticals Inc. Recovers — But Is It SustainableJuly 2025 Sentiment & Verified Momentum Stock Watchlist - 선데이타임즈

Aug 13, 2025
pulisher
Aug 13, 2025

Is it time to cut losses on Corvus Pharmaceuticals Inc.July 2025 Short Interest & Capital Efficiency Focused Strategies - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Can volume confirm reversal in Corvus Pharmaceuticals Inc. [Rate Cut]Long-Term Growth Plans - Newser

Aug 13, 2025
pulisher
Aug 12, 2025

Corvus Pharmaceuticals and the 2025 Catalysts for Soquelitinib: A Dual-Target Biotech Play - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Corvus Pharmaceuticals: Positive Phase 1 Soquelitiinb Trial Data Brings 2025 Catalysts - Seeking Alpha

Aug 12, 2025
pulisher
Aug 12, 2025

Does Corvus Pharmaceuticals Inc. qualify in momentum factor screeningFree High Accuracy Alerts for ROI Traders - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

What makes Corvus Pharmaceuticals Inc. stock price move sharplyMarket Volume Report & Capital Efficient Trading Techniques - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 12, 2025
pulisher
Aug 12, 2025

Long term hold vs stop loss in Corvus Pharmaceuticals Inc.Watchlist Summary for Active Day Traders - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

How Corvus Pharmaceuticals Inc. stock performs during market volatilityStrong Balance Sheet Candidates - thegnnews.com

Aug 12, 2025
pulisher
Aug 12, 2025

Real time pattern detection on Corvus Pharmaceuticals Inc. stockHigh Conviction Screener with Trend Matching - Newser

Aug 12, 2025
pulisher
Aug 11, 2025

How to forecast Corvus Pharmaceuticals Inc. trends using time seriesMarket Correction Proof Stock Screening Analysis - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Advanced analytics toolkit walkthrough for Corvus Pharmaceuticals Inc.Smart Risk Strategy with Entry Optimization - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Published on: 2025-08-11 02:13:29 - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Momentum divergence signals in Corvus Pharmaceuticals Inc. chartFree Triple Digit Return Stock Predictions - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

Is Corvus Pharmaceuticals Inc. stock ready for a breakoutTrend Analysis for Safer Market Entries - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Price action breakdown for Corvus Pharmaceuticals Inc.Free Daily Growth Stock Pick Reports - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Is Now a Good Time to Reenter Corvus Pharmaceuticals Inc.Scalable Portfolio Growth Suggestions Released - beatles.ru

Aug 10, 2025
pulisher
Aug 10, 2025

Corvus (CRVS) Q2 Loss Beats Estimates - AOL.com

Aug 10, 2025
pulisher
Aug 09, 2025

Corvus plans Phase II trial for soquelitinib in atopic dermatitis, targeting 200 patients with 12-week treatment window - MSN

Aug 09, 2025
pulisher
Aug 09, 2025

Traders Watching For Reversal Pattern in Corvus Pharmaceuticals Inc.AI Trading Suggestions With Accuracy Focus Released - metal.it

Aug 09, 2025
pulisher
Aug 09, 2025

Custom strategy builders for tracking Corvus Pharmaceuticals Inc.Free Pattern Detection for Entry Confirmation - Newser

Aug 09, 2025
pulisher
Aug 08, 2025

What recovery options are there for Corvus Pharmaceuticals Inc.Real Chart Based Opportunity Identification - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Transcript : Corvus Pharmaceuticals, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener

Aug 08, 2025
pulisher
Aug 08, 2025

Can technical indicators confirm Corvus Pharmaceuticals Inc.’s reversalFree Short Term Setup With Predictive Chart - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Earnings call transcript: Corvus Pharmaceuticals’ Q2 2025 results show EPS beat By Investing.com - Investing.com South Africa

Aug 08, 2025
pulisher
Aug 08, 2025

Earnings call transcript: Corvus Pharmaceuticals’ Q2 2025 results show EPS beat - Investing.com

Aug 08, 2025
$36.50
price up icon 0.11%
$86.16
price up icon 0.36%
$26.45
price down icon 1.56%
$127.75
price up icon 3.97%
$112.70
price down icon 0.07%
biotechnology ONC
$309.69
price up icon 0.71%
Kapitalisierung:     |  Volumen (24h):